Verónica Corrales‐Sánchez

660 total citations
25 papers, 497 citations indexed

About

Verónica Corrales‐Sánchez is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Verónica Corrales‐Sánchez has authored 25 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Verónica Corrales‐Sánchez's work include Protein Degradation and Inhibitors (9 papers), Cancer-related Molecular Pathways (7 papers) and Microtubule and mitosis dynamics (6 papers). Verónica Corrales‐Sánchez is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Cancer-related Molecular Pathways (7 papers) and Microtubule and mitosis dynamics (6 papers). Verónica Corrales‐Sánchez collaborates with scholars based in Spain, Canada and Slovenia. Verónica Corrales‐Sánchez's co-authors include Alberto Ocaña, Atanasio Pandiella, Eitan Amir, Javier Pérez‐Peña, Arnoud J. Templeton, Boštjan Šeruga, Francisco Vera-Badillo, Cristina Nieto‐Jiménez, Juan Carlos Montero and Mustafa Al-Mubarak and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Verónica Corrales‐Sánchez

24 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verónica Corrales‐Sánchez Spain 13 354 169 143 105 70 25 497
John P. Gustin United States 11 512 1.4× 206 1.2× 150 1.0× 109 1.0× 54 0.8× 12 641
Anchit Khanna Australia 10 512 1.4× 298 1.8× 92 0.6× 112 1.1× 58 0.8× 16 691
Ka Tat Siu United States 10 335 0.9× 186 1.1× 105 0.7× 82 0.8× 41 0.6× 15 500
Weilong Yao China 12 378 1.1× 166 1.0× 102 0.7× 187 1.8× 57 0.8× 17 508
Alexandra Corella United States 8 251 0.7× 161 1.0× 101 0.7× 183 1.7× 66 0.9× 11 438
Kelly E. Fisher United States 4 434 1.2× 288 1.7× 80 0.6× 76 0.7× 91 1.3× 6 599
Eun Mi Je South Korea 12 254 0.7× 79 0.5× 117 0.8× 91 0.9× 69 1.0× 18 440
Tom Januario United States 5 463 1.3× 262 1.6× 126 0.9× 95 0.9× 59 0.8× 8 628
Matias Casás‐Selves United States 8 350 1.0× 175 1.0× 126 0.9× 71 0.7× 28 0.4× 9 549
Eli Wallace United States 9 538 1.5× 296 1.8× 67 0.5× 106 1.0× 111 1.6× 16 697

Countries citing papers authored by Verónica Corrales‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of Verónica Corrales‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Corrales‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Corrales‐Sánchez more than expected).

Fields of papers citing papers by Verónica Corrales‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Corrales‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Corrales‐Sánchez. The network helps show where Verónica Corrales‐Sánchez may publish in the future.

Co-authorship network of co-authors of Verónica Corrales‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Corrales‐Sánchez. A scholar is included among the top collaborators of Verónica Corrales‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Corrales‐Sánchez. Verónica Corrales‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corrales‐Sánchez, Verónica, María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, et al.. (2020). Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer. Journal of Cellular and Molecular Medicine. 24(5). 3117–3127. 13 indexed citations
2.
Serrano‐Oviedo, Leticia, Cristina Nieto‐Jiménez, Miguel Burgos, et al.. (2020). Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer. Cellular Oncology. 43(3). 431–444. 16 indexed citations
3.
Nieto‐Jiménez, Cristina, Eva María Galán‐Moya, Verónica Corrales‐Sánchez, et al.. (2020). Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer. Cancer Letters. 491. 50–59. 18 indexed citations
4.
Serrano‐Oviedo, Leticia, Cristina Jiménez, Verónica Corrales‐Sánchez, et al.. (2020). Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.. Journal of Clinical Oncology. 38(15_suppl). e13098–e13098. 1 indexed citations
5.
Nieto‐Jiménez, Cristina, Verónica Corrales‐Sánchez, Juan Carlos Montero, et al.. (2020). Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer. International Journal of Molecular Sciences. 21(23). 9034–9034. 5 indexed citations
6.
Nieto‐Jiménez, Cristina, Verónica Corrales‐Sánchez, Leticia Serrano‐Oviedo, et al.. (2017). Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer. Molecular Cancer Therapeutics. 16(11). 2552–2562. 45 indexed citations
7.
Pérez‐Peña, Javier, Verónica Corrales‐Sánchez, Eitan Amir, Atanasio Pandiella, & Alberto Ocaña. (2017). Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers. Scientific Reports. 7(1). 17530–17530. 55 indexed citations
8.
Nieto‐Jiménez, Cristina, Javier Pérez‐Peña, Verónica Corrales‐Sánchez, et al.. (2017). Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors. Oncotarget. 8(12). 19478–19490. 23 indexed citations
9.
Santpere, Gabriel, et al.. (2017). Transcriptome evolution from breast epithelial cells to basal-like tumors. Oncotarget. 9(1). 453–463. 12 indexed citations
10.
Nieto‐Jiménez, Cristina, Verónica Corrales‐Sánchez, Leticia Serrano‐Oviedo, et al.. (2017). Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancer.. Journal of Clinical Oncology. 35(15_suppl). e17089–e17089. 1 indexed citations
11.
Pérez‐Peña, Javier, Cristina Nieto‐Jiménez, Verónica Corrales‐Sánchez, et al.. (2017). Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors. Oncotarget. 8(13). 21733–21740. 15 indexed citations
12.
Pérez‐Peña, Javier, Gemma Serrano‐Heras, Juan Carlos Montero, et al.. (2016). In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment. Molecular Cancer Therapeutics. 15(8). 1823–1833. 24 indexed citations
13.
Ocaña, Alberto, Javier Pérez‐Peña, Verónica Corrales‐Sánchez, et al.. (2016). Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer. Breast Cancer Research and Treatment. 156(1). 1–8. 7 indexed citations
14.
Ocaña, Alberto, Javier Pérez‐Peña, Gemma Serrano‐Heras, et al.. (2016). Abstract P3-14-11: Gene-expression analyses identify altered transcription factors and supports the antitumor activity of novel bromodomain inhibitors in triple negative breast cancer. Cancer Research. 76(4_Supplement). P3–14. 1 indexed citations
15.
Ocaña, Alberto, Javier Pérez‐Peña, Verónica Corrales‐Sánchez, et al.. (2016). In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases. Oncotarget. 7(16). 22865–22872. 21 indexed citations
16.
Nieto‐Jiménez, Cristina, et al.. (2016). DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer. Oncotarget. 8(38). 62834–62841. 12 indexed citations
17.
Ocaña, Alberto, Dolores C. Garcı́a-Olmo, Arnoud J. Templeton, et al.. (2015). Circulating DNA and Survival in Solid Tumors. Cancer Epidemiology Biomarkers & Prevention. 25(2). 399–406. 31 indexed citations
18.
Serrano‐Heras, Gemma, Juan Carlos Montero, Verónica Corrales‐Sánchez, et al.. (2015). Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer. Oncotarget. 6(29). 27923–27937. 23 indexed citations
19.
Ocaña, Alberto, Josée-Lyne Ethier, Verónica Corrales‐Sánchez, et al.. (2015). Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses. Oncotarget. 6(37). 39538–39549. 20 indexed citations
20.
Ocaña, Alberto, Francisco Vera-Badillo, Mustafa Al-Mubarak, et al.. (2014). Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis. PLoS ONE. 9(4). e95219–e95219. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John P. Gustin Breakdown of academic impact, for papers by Anchit Khanna Breakdown of academic impact, for papers by Ka Tat Siu Breakdown of academic impact, for papers by Weilong Yao Breakdown of academic impact, for papers by Alexandra Corella Breakdown of academic impact, for papers by Kelly E. Fisher Breakdown of academic impact, for papers by Eun Mi Je Breakdown of academic impact, for papers by Tom Januario Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Eli Wallace
Rankless by CCL
2026